Cargando…

The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention

BACKGROUND: We have little understanding of how vapers use e-cigarettes beyond cessation. E-cigarettes may have a role to play in reducing the health-related harms of tobacco smoking, through not only assisting smoking cessation attempts but also supporting long-term abstinence from smoking. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Notley, Caitlin, Ward, Emma, Dawkins, Lynne, Holland, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011187/
https://www.ncbi.nlm.nih.gov/pubmed/29921278
http://dx.doi.org/10.1186/s12954-018-0237-7
_version_ 1783333754078494720
author Notley, Caitlin
Ward, Emma
Dawkins, Lynne
Holland, Richard
author_facet Notley, Caitlin
Ward, Emma
Dawkins, Lynne
Holland, Richard
author_sort Notley, Caitlin
collection PubMed
description BACKGROUND: We have little understanding of how vapers use e-cigarettes beyond cessation. E-cigarettes may have a role to play in reducing the health-related harms of tobacco smoking, through not only assisting smoking cessation attempts but also supporting long-term abstinence from smoking. However, there are fears that vaping may lead to the ‘renormalisation’ of smoking type behaviours. This study aimed to explore patterns of use and reported experiences of vapers quitting smoking using an e-cigarette in relation to long-term smoking status (abstinence or relapse). METHODS: A purposive sample of 40 UK vapers was matched to a sampling frame of demographic characteristics from a representative sample of UK quitters. Following full informed consent, semi-structured qualitative interviews were conducted. Data were thematically analysed by two members of the research team. Final thematic analysis was verified and agreed by consensus. RESULTS: The sample self-reported long histories of tobacco use and multiple previous quit attempts which had eventually resulted in relapse back to smoking, although a small but important group had never before attempted to quit. Initiating e-cigarette use was experienced as a revelation for some, who were quickly able to fully switch to using e-cigarettes as an alternative to tobacco smoking. For others, periods of dual use or smoking relapse combined with attempts at vaping that were not initially satisfactory. Many of these chose a cheaper ‘cig-a-like’ device which they found to be inadequate. Experimentation with different devices and different setups, over time, resulted in some ‘sliding’ rather than switching to vaping. This involved periods of ‘dual use’. Some settled on patterns of vaping as a direct substitute of previous tobacco smoking, whereas others reported ‘grazing’ patterns of vaping throughout the day that were perceived to support tobacco smoking abstinence. CONCLUSIONS: Our data demonstrates that e-cigarettes may be a unique harm reduction innovation for smoking relapse prevention. E-cigarettes meet the needs of some ex-smokers by substituting physical, psychological, social, cultural and identity-related aspects of tobacco addiction. Some vapers reported that they found vaping pleasurable and enjoyable—being more than a substitute but actually preferred, over time, to tobacco smoking. This clearly suggests that vaping is a viable long-term substitute for smoking, with substantial implications for tobacco harm reduction.
format Online
Article
Text
id pubmed-6011187
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60111872018-06-27 The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention Notley, Caitlin Ward, Emma Dawkins, Lynne Holland, Richard Harm Reduct J Research BACKGROUND: We have little understanding of how vapers use e-cigarettes beyond cessation. E-cigarettes may have a role to play in reducing the health-related harms of tobacco smoking, through not only assisting smoking cessation attempts but also supporting long-term abstinence from smoking. However, there are fears that vaping may lead to the ‘renormalisation’ of smoking type behaviours. This study aimed to explore patterns of use and reported experiences of vapers quitting smoking using an e-cigarette in relation to long-term smoking status (abstinence or relapse). METHODS: A purposive sample of 40 UK vapers was matched to a sampling frame of demographic characteristics from a representative sample of UK quitters. Following full informed consent, semi-structured qualitative interviews were conducted. Data were thematically analysed by two members of the research team. Final thematic analysis was verified and agreed by consensus. RESULTS: The sample self-reported long histories of tobacco use and multiple previous quit attempts which had eventually resulted in relapse back to smoking, although a small but important group had never before attempted to quit. Initiating e-cigarette use was experienced as a revelation for some, who were quickly able to fully switch to using e-cigarettes as an alternative to tobacco smoking. For others, periods of dual use or smoking relapse combined with attempts at vaping that were not initially satisfactory. Many of these chose a cheaper ‘cig-a-like’ device which they found to be inadequate. Experimentation with different devices and different setups, over time, resulted in some ‘sliding’ rather than switching to vaping. This involved periods of ‘dual use’. Some settled on patterns of vaping as a direct substitute of previous tobacco smoking, whereas others reported ‘grazing’ patterns of vaping throughout the day that were perceived to support tobacco smoking abstinence. CONCLUSIONS: Our data demonstrates that e-cigarettes may be a unique harm reduction innovation for smoking relapse prevention. E-cigarettes meet the needs of some ex-smokers by substituting physical, psychological, social, cultural and identity-related aspects of tobacco addiction. Some vapers reported that they found vaping pleasurable and enjoyable—being more than a substitute but actually preferred, over time, to tobacco smoking. This clearly suggests that vaping is a viable long-term substitute for smoking, with substantial implications for tobacco harm reduction. BioMed Central 2018-06-20 /pmc/articles/PMC6011187/ /pubmed/29921278 http://dx.doi.org/10.1186/s12954-018-0237-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Notley, Caitlin
Ward, Emma
Dawkins, Lynne
Holland, Richard
The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention
title The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention
title_full The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention
title_fullStr The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention
title_full_unstemmed The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention
title_short The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention
title_sort unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011187/
https://www.ncbi.nlm.nih.gov/pubmed/29921278
http://dx.doi.org/10.1186/s12954-018-0237-7
work_keys_str_mv AT notleycaitlin theuniquecontributionofecigarettesfortobaccoharmreductioninsupportingsmokingrelapseprevention
AT wardemma theuniquecontributionofecigarettesfortobaccoharmreductioninsupportingsmokingrelapseprevention
AT dawkinslynne theuniquecontributionofecigarettesfortobaccoharmreductioninsupportingsmokingrelapseprevention
AT hollandrichard theuniquecontributionofecigarettesfortobaccoharmreductioninsupportingsmokingrelapseprevention
AT notleycaitlin uniquecontributionofecigarettesfortobaccoharmreductioninsupportingsmokingrelapseprevention
AT wardemma uniquecontributionofecigarettesfortobaccoharmreductioninsupportingsmokingrelapseprevention
AT dawkinslynne uniquecontributionofecigarettesfortobaccoharmreductioninsupportingsmokingrelapseprevention
AT hollandrichard uniquecontributionofecigarettesfortobaccoharmreductioninsupportingsmokingrelapseprevention